FDA Inspection 1301806 — Boris Mladenov, MD
The FDA completed an inspection of Boris Mladenov, MD on Jan 9, 2026 in Sofiya. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 9, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Sofiya (Bulgaria)
Additional details
Clinical Investigator (CI)